The chemistry of enalapril.

The design origins of the potent non-mercapto angiotensin converting enzyme inhibitors enalaprilat and its mono ethyl ester enalapril are described. Lactam analogues of enalaprilat have provided some insight into the conformation of this inhibitor when it is bound to converting enzyme. X-ray crystallographic studies of a related enzyme/inhibitor complex offer an explanation for the high potency and specificity of these and related inhibitors.

[1]  J. Snyder,et al.  Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations. , 1986, Journal of medicinal chemistry.

[2]  B. Matthews,et al.  Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases. , 1984, Biochemistry.

[3]  Sweet Cs.  Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421). , 1983 .

[4]  D. Vidt,et al.  Medical intelligence drug therapy: captopril. , 1982, The New England journal of medicine.

[5]  D. Hangauer.  A one-step synthesis of ethyl 4-(β-indolyl)-2-ketobutyrate via polyanion chemistry and its conversion into angiotensin converting enzyme inhibitors , 1981 .

[6]  A. Patchett,et al.  Inhibition of thermolysin by N-carboxymethyl dipeptides. , 1981, Biochemical and biophysical research communications.

[7]  J. Biollaz,et al.  Three new long‐acting converting‐enzyme inhibitors: Relationship between plasma converting‐enzyme activity and response to angiotensin I , 1981, Clinical pharmacology and therapeutics.

[8]  C. A. Stone,et al.  A new class of angiotensin-converting enzyme inhibitors , 1980, Nature.

[9]  D W Cushman,et al.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. , 1977, Biochemistry.

[10]  B Rubin,et al.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.

[11]  R. Wolfenden,et al.  Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A. , 1973, Biochemistry.

[12]  R. Wolfenden,et al.  A potent reversible inhibitor of carboxypeptidase A. , 1972, The Journal of biological chemistry.

[13]  C. Sweet.  Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421). , 1983, Federation proceedings.

[14]  M. Ondetti,et al.  Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions , 1982, Medicinal research reviews.

[15]  M. Ondetti,et al.  2 Inhibitiors of Angiotensin-Converting Enzyme , 1980 .

[16]  M. Ondetti,et al.  INHIBITORS OF ANGIOTENSIN I CONVERTING ENZYME , 1980 .

[17]  R. Wolfenden,et al.  Erratum: Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A (Biochemistry (1973) 12 11 (2070-2077)) , 1973 .